ID

16215

Descripción

A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00102219

Link

https://clinicaltrials.gov/show/NCT00102219

Palabras clave

  1. 5/7/16 5/7/16 -
Subido en

5 de julio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00102219

Eligibility Breast Cancer NCT00102219

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of locally advanced or metastatic breast cancer that is not amenable to local treatment.
Descripción

Locally advanced breast cancer | Carcinoma breast stage IV Amenable Local Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3495949
UMLS CUI [2,1]
C0278488
UMLS CUI [2,2]
C3900053
UMLS CUI [2,3]
C1517925
patients must be chemo-naive or have received only neoadjuvant and/or adjuvant chemotherapy.
Descripción

Chemotherapy naive | Neoadjuvant Chemotherapy | Chemotherapy, Adjuvant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0919936
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C0392920
UMLS CUI [3]
C0085533
at least one measurable lesion.
Descripción

Measurable lesion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
no chemotherapy within 4 weeks prior to enrollment.
Descripción

Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
signed informed consent from the patient.
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy for metastatic breast cancer.
Descripción

Prior Chemotherapy Metastatic breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0278488
prior treatment with any anthracyclines or anthracenedione-containing regimen.
Descripción

Anthracyclines | Anthraquinones

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0282564
UMLS CUI [2]
C0003174
treatment within the last 30 days with any drug that has not received regulatory approval.
Descripción

Drugs, Non-Prescription

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013231
pregnancy and/or breast feeding.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
inability or unwillingness to take folic acid or vitamin b12 supplementation.
Descripción

Unable to take Folic Acid | Unable to take Vitamin B12 supplement | Folic Acid Intake Unwilling | Vitamin B12 supplement Intake Unwilling

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4074979
UMLS CUI [1,2]
C0016410
UMLS CUI [2,1]
C4074979
UMLS CUI [2,2]
C3661610
UMLS CUI [3,1]
C0016410
UMLS CUI [3,2]
C1512806
UMLS CUI [3,3]
C0558080
UMLS CUI [4,1]
C3661610
UMLS CUI [4,2]
C1512806
UMLS CUI [4,3]
C0558080

Similar models

Eligibility Breast Cancer NCT00102219

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Locally advanced breast cancer | Carcinoma breast stage IV Amenable Local Therapy
Item
diagnosis of locally advanced or metastatic breast cancer that is not amenable to local treatment.
boolean
C3495949 (UMLS CUI [1])
C0278488 (UMLS CUI [2,1])
C3900053 (UMLS CUI [2,2])
C1517925 (UMLS CUI [2,3])
Chemotherapy naive | Neoadjuvant Chemotherapy | Chemotherapy, Adjuvant
Item
patients must be chemo-naive or have received only neoadjuvant and/or adjuvant chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0600558 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3])
Measurable lesion
Item
at least one measurable lesion.
boolean
C1513041 (UMLS CUI [1])
Chemotherapy
Item
no chemotherapy within 4 weeks prior to enrollment.
boolean
C0392920 (UMLS CUI [1])
Informed consent
Item
signed informed consent from the patient.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy Metastatic breast cancer
Item
prior chemotherapy for metastatic breast cancer.
boolean
C1514457 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])
Anthracyclines | Anthraquinones
Item
prior treatment with any anthracyclines or anthracenedione-containing regimen.
boolean
C0282564 (UMLS CUI [1])
C0003174 (UMLS CUI [2])
Drugs, Non-Prescription
Item
treatment within the last 30 days with any drug that has not received regulatory approval.
boolean
C0013231 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy and/or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Unable to take Folic Acid | Unable to take Vitamin B12 supplement | Folic Acid Intake Unwilling | Vitamin B12 supplement Intake Unwilling
Item
inability or unwillingness to take folic acid or vitamin b12 supplementation.
boolean
C4074979 (UMLS CUI [1,1])
C0016410 (UMLS CUI [1,2])
C4074979 (UMLS CUI [2,1])
C3661610 (UMLS CUI [2,2])
C0016410 (UMLS CUI [3,1])
C1512806 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
C3661610 (UMLS CUI [4,1])
C1512806 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial